Abstract
Objectives Timely, accurate reporting of pregnancy vaccination coverage is key to evaluating pregnancy immunisation programs. We compared influenza and pertussis vaccination reporting on the New South Wales (NSW) Perinatal Data Collection (PDC) and the Australian Immunisation Register (AIR), to understand coverage, reporting, timing of vaccination and provider type.
Design Retrospective population-based cohort study.
Setting People giving birth at ≥20-weeks gestation (2017–2022) in the NSW PDC, linked to AIR-reported influenza and pertussis vaccinations.
Main outcome measures Influenza and pertussis coverage according to 1) the PDC and 2) linked AIR records, and agreement between data sources by year (influenza: 2021–2022, pertussis: 2017–2022) and selected characteristics (2022). Description of provider type and timing for vaccinations reported to the AIR (2022).
Results PDC-reported influenza and pertussis coverage peaked in 2020 (influenza: 58.8% (52,940/90,091), pertussis: 79.0% (71,169/90,091)), decreasing thereafter (influenza: 49.1% (43,744/89,112), pertussis: 77.6% (69,129/89,112) in 2022). Influenza and pertussis vaccination coverage as reported to the AIR increased from 34.7% (33,611/96,789) in 2021 to 44.8% (39,935/89,112) in 2022 and 24.4% (22,857/93,582) in 2017 to 51.6% (46,009/89,112) in 2022, respectively. Agreement between AIR and PDC improved over time, but remained suboptimal (influenza: 75.5%, pertussis: 56.6% in 2022). AIR and PDC agreement differed most by antenatal care model, particularly for pertussis vaccinations. In 2022, of pregnancy vaccinations reported to the AIR, >75% were provided in general practices. Co- administration occurred infrequently (8.8%).
Conclusions Despite mandated reporting to the AIR, there was significant underreporting of pregnancy vaccinations to the AIR as compared with the NSW PDC. National collection of accurate and timely data on pregnancy vaccination coverage is needed to monitor vaccine uptake, and identify and monitor strategies to improve uptake, particularly with the new pregnancy RSV vaccine program in 2025. We identified co-administration as a potential strategy to improve influenza vaccination coverage during pregnancy.
Competing Interest Statement
KM's institution has received funding from Australian and State Government Departments of Health, Australian National Health and Medical Research Council, GAVI, WHO and Wellcome Trust. KM has served as an expert witness for State Governments. BL's institution receives grant funding from the Australian National Health and Medical Research Council and the Medical Research Future Fund and Wellcome Trust. From 2019-2023 BL was a member of the Australian Technical Advisory Group on Immunisation.
Funding Statement
This study was funded by: University of New South Wales SPH Grant Building Support Scheme/School of Population Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was approved by the NSW Population and Health Service Research Ethics Committee (reference number 2021/ETH01116).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in this research are available to researchers on request and subject to approval from the relevant data custodians and ethics committees. The authors do not have permission to share data.
